
CoLucid Pharmaceuticals
Developing oral lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain by health care professionals.
Employees
Enterprise value
$960m
Authorizing premium user...
Developing oral lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain by health care professionals.